Havrdova E, Arnold DL, Cohen JA, et al. Alemtuzumab CAREMS
I 5-year follow-up. Neurology 2017;89(11):1107–1116.
Zimmermann J, Buhl T, Müller M. Alopecia Universalis following Alemtuzumab treatment in multiple sclerosis: a barely
recognized manifestation...
Ruck T, Pfeuffer S, Schulte-Mecklenbeck A, et al. Vitiligo after
alemtuzumab treatment. Neurology 2018;91(24):e2233–e2237.
Böhm M, Kemp E, Metze D, et al. Alemtuzumab-induced halo
naevus-like hypopigmentation – new insights into secondary
skin autoimmunity in response...
Distler O, Cozzio A. Systemic sclerosis and localized scleroderma—current concepts and novel targets for therapy. Semin
Immunopathol. 2015;38(1):87–95.